The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials.

The record

Year: 2023
Journal: Diabetes & metabolic syndrome
Pages: 102729
Authors: L. Setayesh, Neda Haghighat, Niloufar Rasaei, M. Rezaei, K. Casazza, Maryam Nadery, I. Yamrali, M. Zamani, Omid Asbaghi
DOI: 10.1016/j.dsx.2023.102729

Source bibliography; study design, findings and full text have not been independently reviewed.